Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Vanguard Value Index Fund ETF (VTV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Vanguard Value Index Fund ETF — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Vanguard Value Index Fund ETF trades at $221.23 (market cap $262.40B). The key difference: Vanguard Value Index Fund ETF is far larger — about 269.7× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Vanguard Value Index Fund ETF is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Vanguard Value Index Fund ETF for 143 Days on average.
| MRVI | VTV | |
|---|---|---|
Market Cap | $972.90M | $262.40B |
Volume | 4,325,710 | 1,774,364 |
Sector | Health | — |
52-Week High | $9.00 | $227.51 |
52-Week Low | $2.83 | $182.89 |
Typical Hold Time | 0 Days | 143 Days |
Enterprise Value | $1.08B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
VTV trades at $221.14, down 0.13% on the day, with a bullish technical signal from moving averages but overbought RSI levels. The ETF offers a 2.3% dividend yield and has attracted institutional inflows, with recent news highlighting its outperformance versus growth funds in 2026. Value stocks are gaining favor amid market rotation away from tech concentration.
Outlook remains positive given value's momentum and institutional interest, though risks include prolonged underperformance versus growth and fee-related long-term tracking differences. The ETF provides stable income and diversification but faces competition from broader market funds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →
